VVOS PRESS-RELEASE SEC Filing Analysis

Latest settled — T+5d

VVOS ▲ +14.53% at T+5d

NEUTRAL call ✓ call won +14.53% · α vs SPY +12.93% · entry $0.5850 → $0.6700

Next anchor: T+20d in 3d

Last close $0.5720 (close Jun 12) · -2.22% from $0.5850 entry

Entry anchored
May 20, 03:49 PM ET
via Databento tick

T+1d

+4.27%

call +4.27% · α +3.83%

$0.6100

settled 25d ago

T+5d

+14.53%

call +14.53% · α +12.93%

$0.6700

settled 18d ago

T+20d

—

call — · α —

—

in 3d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

Vivos Therapeutics reported Q1 2026 revenue of $5.14M (+70% YoY, 19.6% above consensus) but EPS of -$0.52 missed estimates by 15.6%. The net loss doubled to $7.75M due to higher operating expenses, including one-time items. The company has negative stockholders' equity and needs additional funding.

Key Financial Metrics

Gross Margin

60%

Actionable Insight

The strong revenue growth is encouraging but the widening loss and cash burn raise concerns. Monitor for capital raise or restructuring announcements. The next catalyst is the ability to achieve positive cash flow.

Key Facts

Revenue $5.14M vs consensus $4.3M (beat by 19.6%)
EPS -$0.52 vs consensus -$0.45 (miss by 15.6%)
Gross margin improved to 60% from 50%
Net loss widened to $7.75M from $3.86M
Cash $2.1M, stockholders' deficit -$1.1M

Financial Impact

Revenue beat of $0.84M (19.6%) but EPS miss of $0.07 (15.6%)

revenueepsnet losscash

Risk Factors

Need for additional funding leading to dilution
Going concern risk due to negative equity
High cash burn rate

Market Snapshot

Exchange

Nasdaq

Sector

Surgical & Medical Instruments & Apparatus

Analyst Consensus

78% bullish (9 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3298869

7 reports for VVOS

T+1T+5T+20T+60

100% Hit rate 3 of 3 directional calls best @ T+20▲ +50.61%Apr 15, 2026

Filters

Reports for VVOS — sortable, filterable
	Type				Now
Jun 8, 2026 6d ago	8-K BEARISH ★ 7/10	$0.7600 awaiting T+5	awaiting T+5	—	$0.5720 (+24.74%)
May 20, 2026 25d ago	Press Release MIXED ★ 5/10	$0.5850 $0.6700	▲ +14.53%	▲ +12.93%	$0.5720 (−2.22%)
Apr 15, 2026 8w ago	8-K MIXED ★ 6/10	$1.09 $0.8960	▼ −17.80%	▼ −18.78%	$0.5720 (−47.52%)
Apr 15, 2026 8w ago	Press Release BEARISH ★ 6/10	$1.09 $0.8960	▲ +17.80%	▲ +18.78%	$0.5720 (+47.52%)
Apr 15, 2026 8w ago	Press Release BEARISH ★ 6/10	$1.47 $1.03	▲ +29.93%	▲ +31.57%	$0.5720 (+61.09%)
Apr 7, 2026 9w ago	Press Release NEUTRAL ★ 5/10	$1.24 $1.35	▲ +8.87%	▲ +3.54%	$0.5720 (−53.87%)
Apr 3, 2026 10w ago	8-K BEARISH ★ 7/10	$1.31 $1.22	▲ +6.87%	▲ +11.00%	$0.5720 (+56.34%)

US Market Status

Market Closed — Opens in 4h 19m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access